Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study
Authors:
- Justyna ŻubrowskaJŻJustyna Żubrowska
- Małgorzata PieniążekMPMałgorzata Pieniążek
- Anna Polakiewicz-GilowskaAPAnna Polakiewicz-Gilowska
- Lenka RušinováLRLenka Rušinová
- Renáta SoumarováRSRenáta Soumarová
- Hana ŠtudentováHŠHana Študentová
- Aleksandra KoniecznaAKAleksandra Konieczna
- Agnieszka MłodzińskaAMAgnieszka Młodzińska
- Karolina Winsko-SzczęsnowiczKWKarolina Winsko-Szczęsnowicz
- Maja Lisik-HabibMLMaja Lisik-Habib
- Anika PękalaAPAnika Pękala
- Daniel KrejčíDKDaniel Krejčí
Open Access
- 12 January 2026
- journal article
- Published by Elsevier in The Breast
- Vol. 85, 104699
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of lifeCancer, 2024
- 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)The Breast, 2024
- Systemic Anticancer Treatment Near the End of Life: a Narrative Literature ReviewCurrent Treatment Options in Oncology, 2023
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAnnals of Oncology, 2021
- Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational studyClinics and Research in Hepatology and Gastroenterology, 2021
- Care of the adult cancer patient at the end of life: ESMO Clinical Practice GuidelinesESMO Open, 2021
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trialThe Lancet, 2020
- Chemotherapy use near the end-of-life in patients with metastatic breast cancerBreast Cancer Research and Treatment, 2020
- Prognostic factors in patients who received end-of-life chemotherapy for advanced cancerInternational Journal of Clinical Oncology, 2018
- Chemotherapy at the end of life: up until when?Clinical and Translational Oncology, 2012